No Treatment Received Nomed


Combined with:

Myfortic
Sandimmune

Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 83.3%
Thrombosis Prophylaxis 16.7%
Hypoaesthesia Facial 50.0%
Vomiting 50.0%
Secondary
Renal Transplant 70.2%
Liver Transplant 12.6%
Hypertension 5.1%
Heart Transplant 2.3%
Prophylaxis 2.0%
Coronary Artery Disease 0.9%
Nephropathy 0.9%
Cardiomyopathy 0.7%
Hypercholesterolaemia 0.7%
Immunosuppression 0.7%
Infection 0.7%
Hyperlipidaemia 0.5%
Prostate Cancer 0.5%
Arrhythmia 0.4%
Prophylaxis Against Transplant Rejection 0.4%
Stent Placement 0.4%
Essential Hypertension 0.3%
Hyperuricaemia 0.3%
Breast Cancer 0.2%
Diabetes Mellitus 0.2%
Urinary Tract Infection 11.2%
Vomiting 9.6%
Pyrexia 8.8%
Renal Failure 7.2%
Sepsis 6.4%
Lymphocele 5.6%
Seroma 5.6%
Wound Secretion 4.8%
Tachyarrhythmia 4.0%
Transplant Failure 4.0%
Urethritis 4.0%
Alveolitis 3.2%
Leukopenia 3.2%
Lymphocele Marsupialisation 3.2%
Oedema Peripheral 3.2%
Orthostatic Intolerance 3.2%
Pneumonia 3.2%
Renal Tubular Disorder 3.2%
Stent Placement 3.2%
Surgery 3.2%

Drug Data